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BACKGROUND
• Inflammation plays an important role in the aetiology and pathogenesis of atherosclerosis
and plaque formation.
• Tumour necrosis factor-alpha (TNF-α) is a
mediator of systemic inflammation and
implicated in the pathogenesis of
atherogenesis/atherosclerosis.
Steyers et al., 2014; Int. J. Mol. Sci. 15:11324-49.
• TNF-α induces the transcription factor NF-
κB leading to enhanced expression of
intercellular adhesion molecules, vascular
endothelial and fibroblast growth factors,
chemokines that promote the recuitment
and the adhesion of monocytes to inflamed
luminal endothelium triggering the
atherogenic process.
• ACNs may prevent endothelial cells dysfunction thanks to their capacity to modulate the
expression and activity of several enzymes involved in nitric oxide (NO) metabolism by
influencing NO levels.
• Anthocyanins (ACNs) are a group of abundant and widely consumed flavonoids
providing the red, blue, violet colors at many fruit- and vegetable-based food products.
• Furthermore, ACNs can down-
regulate the expression of
adhesion molecules and prevent
the adhesion of monocytes to
endothelial cells challenged by
pro-inflammatory agents.
Speciale et al., 2014 Genes Nutr. 9:404
• The link between atherogenesis and health promoting effect of ACNs has not been
deeply clarified and some studies reported a different effect depending on the compound
tested.
• Most of ACNs are rapidly transformed by human gut in metabolic products, reaching a
plasmatic concentration much higher than that of parental ACNs, and their contribution
in the biological activity observed should be considered.
Karga et al., 2016 Arch. Biochem. Biophys. 599:51-9.
AIM OF THE STUDY
To investigate the capacity of anthocyanins and related metabolites to
counteract inflammation and atherogenic process through the
evaluation of monocytes (THP-1) adhesion to stimulated endothelial
cells (HUVECs), and the levels of E-selectin and VCAM-1 as
potential molecules involved in such modulation.
ACNs
Delphinidin 3-glucoside (Dp 3-glc)




Petunidin 3-glucoside (Pet 3-glc)
Vanillic acid (VA)
Malvidin 3-glucoside (Mv 3-glc)




3-Methyl Gallic acid 
(3-MetGa A)
• Day 1-Preparation of 96 wells plate (2x104 HUVEC per well);
• Day 2-Labelling of THP-1 cells with CellTrackerTM Green CMFDA, addition of 
THP-1 (2x105 cells/well) and TNF- (100 ng mL-1) to HUVEC, and incubation for 
24h; 
• Day 3-Incubation with ACNs or meabolites at different concentrations (from 0.01
till 10μg mL-1);
• Day 4- Reading of the fluorescence (excitation: 485 nm, emission: 538 nm, mod.
F200 Infinite, TECAN Milan, Italy)
METHODS: PROTOCOL TO STUDY THE ANTI-INFLAMMATORY AND 
ANTIATHEROGENIC ACTIVITY OF ACNs AND METABOLITES
Supernatants were collected for the evaluation of markers of inflammation and vascular
function (e.g. E-selectin, VCAM-1, VEGF) by ELISA kits
Malvidin-3-glucoside Syringic acid
Significant reduction of THP-1 adhesion to HUVEC at
all concentrations tested with respect to the control
treatment with TNF-α. Maximum reduction at 10
µg/mL-1 (-33.9%; p<0.001).




























































































Significant reduction after VA only at the maximum
concentration (-20.8%; p<0.005).
Significant reduction of THP-1 adhesion to HUVEC at
all concentrations tested with respect to the control






















































































































































































































































































































































RESULTS: Effect of ACNs and metabolites on VCAM-1 concentration
1-Mv and Peo-3-glc showed to counteract THP-1 adhesion to HUVEC, while the
effects of metabolites seem to be compound dependent and only at high doses.
CONCLUSIONS
3-Since the effects were observed at the low doses, these results could suggest that
the protective effect may be reached also in vivo at physiological concentrations.
2-ACNs and metabolites seem to reduce the production of E-selectin, but not
VCAM-1.
4-Ongoing experiments are attempting to confirm and clarify the mechanisms of
action of each compound involved in the above observations.
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